acetylcysteine has been researched along with carvedilol in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Domoto, K; Ishikawa, Y; Kawasaki, S; Okuda, M; Taguchi, M; Takahashi, A; Takahashi, T; Taniguchi, T; Yokoyama, M | 1 |
| Chang, H; Fang, WJ; Liou, JY; Shyu, KG; Wang, BW | 1 |
| Altieri, P; Barisione, C; Barsotti, A; Brunelli, C; Fabbi, P; Garibaldi, S; Ghigliotti, G; Manca, V; Patrone, F; Spallarossa, P | 1 |
| Akcay, S; Dogan, A; Erdogan, D; Icli, A; Okutan, H; Ozaydin, M; Peker, O; Varol, E; Yucel, H | 1 |
| Akcay, S; Ceyhan, BM; Dogan, A; Erdogan, D; Icli, A; Okutan, H; Ozaydin, M; Peker, O; Sutcu, R; Uysal, BA; Varol, E; Yucel, H | 1 |
| Akcay, S; Dogan, A; Erdogan, D; Icli, A; Okutan, H; Ozaydin, M; Peker, T; Uysal, BA; Varol, E; Yucel, H | 1 |
| Ghafari, R; Habibi, V; Heydari, S; Iranian, M; Jalalian, R; Maleki, M | 1 |
1 review(s) available for acetylcysteine and carvedilol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for acetylcysteine and carvedilol
| Article | Year |
|---|---|
Metoprolol vs. carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study.
Topics: Acetylcysteine; Adult; Aged; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Carbazoles; Carvedilol; Coronary Artery Bypass; Double-Blind Method; Drug Therapy, Combination; Humans; Length of Stay; Metoprolol; Middle Aged; Postoperative Complications; Propanolamines; Treatment Outcome; Young Adult | 2013 |
Oxidative status, inflammation, and postoperative atrial fibrillation with metoprolol vs carvedilol or carvedilol plus N-acetyl cysteine treatment.
Topics: Acetylcysteine; Aged; Antihypertensive Agents; Atrial Fibrillation; Carbazoles; Cardiac Surgical Procedures; Carvedilol; Double-Blind Method; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Inflammation; Leukocyte Count; Male; Metoprolol; Middle Aged; Oxidative Stress; Postoperative Period; Propanolamines; Prospective Studies; Treatment Outcome | 2014 |
Addition of N-acetyl cysteine to carvedilol decreases the incidence of acute renal injury after cardiac surgery.
Topics: Acetylcysteine; Acute Kidney Injury; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Carbazoles; Cardiac Surgical Procedures; Carvedilol; Creatinine; Double-Blind Method; Female; Humans; Incidence; Male; Metoprolol; Middle Aged; Propanolamines; Prospective Studies; Time Factors; Treatment Outcome; Turkey | 2014 |
Comparing the efficacy of N-acetylcysteine plus carvedilol versus carvedilol in the prevention of atrial fibrillation following coronary artery bypass graft surgery.
Topics: Acetylcysteine; Adrenergic beta-Antagonists; Atrial Fibrillation; Carvedilol; Coronary Artery Bypass; Humans; Postoperative Complications | 2022 |
6 other study(ies) available for acetylcysteine and carvedilol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Participation of reactive oxygen intermediates in the angiotensin II-activated signaling pathways in vascular smooth muscle cells.
Topics: Acetylcysteine; Angiotensin II; Animals; Antioxidants; Aorta, Thoracic; Carbazoles; Carvedilol; Cells, Cultured; Epidermal Growth Factor; Hydrogen Peroxide; Muscle, Smooth, Vascular; Propanolamines; Rats; Reactive Oxygen Species; Signal Transduction; Tetradecanoylphorbol Acetate | 2000 |
Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart.
Topics: Acetylcysteine; Animals; Antihypertensive Agents; Aorta; Arteries; Blotting, Western; Body Weight; Carbazoles; Carvedilol; Down-Regulation; Doxazosin; Echocardiography; Hemodynamics; Hypertrophy; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Myocardium; Nerve Growth Factor; Organ Size; Pressure; Propanolamines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Transcription Factors; Valine; Valsartan; Vascular Endothelial Growth Factor A; Vasodilator Agents | 2005 |
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis.
Topics: Acetylcysteine; Animals; Apoptosis; Atenolol; Carbazoles; Carvedilol; Cell Line; Doxorubicin; Flow Cytometry; Free Radicals; Hydrogen Peroxide; Myocytes, Cardiac; Propanolamines; Rats; Razoxane; Receptors, LDL; Receptors, Oxidized LDL; RNA, Messenger; Scavenger Receptors, Class E; Up-Regulation | 2005 |